Prism Advisors Inc. Buys Shares of 29,633 SPDR S&P China ETF (NYSEARCA:GXC)

Prism Advisors Inc. bought a new stake in shares of SPDR S&P China ETF (NYSEARCA:GXC) in the 4th quarter, Holdings Channel.com reports. The fund bought 29,633 shares of the company’s stock, valued at approximately $2,019,000. SPDR S&P China ETF comprises approximately 0.6% of Prism Advisors Inc.’s investment portfolio, making the stock its 24th largest position.

Several other hedge funds have also recently added to or reduced their stakes in the business. Qube Research & Technologies Ltd purchased a new stake in shares of SPDR S&P China ETF during the third quarter worth about $39,000. Barclays PLC grew its holdings in shares of SPDR S&P China ETF by 374.0% during the first quarter. Barclays PLC now owns 1,844 shares of the company’s stock worth $152,000 after buying an additional 1,455 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of SPDR S&P China ETF during the fourth quarter worth about $219,000. HighTower Advisors LLC acquired a new stake in shares of SPDR S&P China ETF in the first quarter worth approximately $226,000. Finally, Raymond James & Associates acquired a new stake in shares of SPDR S&P China ETF in the fourth quarter worth approximately $233,000.

SPDR S&P China ETF Stock Down 0.3 %

Shares of GXC traded down $0.19 during mid-day trading on Friday, hitting $65.33. The company had a trading volume of 19,281 shares, compared to its average volume of 164,913. The business’s 50-day simple moving average is $65.53 and its 200-day simple moving average is $66.83. SPDR S&P China ETF has a 1-year low of $59.45 and a 1-year high of $81.72. The stock has a market cap of $476.91 million, a PE ratio of 8.99 and a beta of 0.86.

SPDR S&P China ETF Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.